 | Up a level |
2022
Koschmieder, Steffen, Isfort, Susanne, Heidel, Florian H., Hochhaus, Andreas, Becker, Heiko, Jost, Philipp J., Schafhausen, Philippe, Griesshammer, Martin, Wolleschak, Denise, Haenel, Mathias, Goethert, Joachim R., Teichmann, Lino L., Sockel, Katja, Radsak, Markus P., Reiter, Andreas, Doehner, Konstanze, Balleisen, Sebastian, Jaekel, Nadja, von Bubnoff, Nikolas, Stegelmann, Frank, Gezer, Deniz, Kortmann, Maike, Frank, Julia, Hellmich, Martin and Bruemmendorf, Tim H. (2022). Ruxolitinib Versus Best Available Therapy in Patients with Essential Thrombocythemia: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN). Blood, 140. S. 1790 - 1794. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
2021
Juette, Bianca B., Krollmann, Calvin, Cieslak, Kevin, Koerber, Ruth-Miriam, Boor, Peter, Graef, Claus M., Bartok, Eva 
ORCID: 0000-0003-0556-1950, Wagner, Mirko, Carell, Thomas, Landsberg, Jennifer, Aymans, Pia, Wenzel, Jorg, Brossart, Peter and Teichmann, Lino L.
(2021).
Intercellular cGAMP transmission induces innate immune activation and tissue inflammation in Trex1 deficiency.
iScience, 24 (8).
CAMBRIDGE:
CELL PRESS.
ISSN 2589-0042